Synopsis
Longevity Industry 3.0 represents the next evolutionary phase in the Longevity revolution, following the foundational insights of Longevity Industry 1.0 and Longevity Industry 2.0. In this groundbreaking volume, Dmitry Kaminskiy and his team at Deep Knowledge Group expand the concept of longevity beyond individual health to embrace species-wide longevity strategies, with an emphasis on global health, technological integration, and sustainable human survival in the face of both terrestrial and existential challenges.
Building on the frameworks of its predecessors, Longevity Industry 3.0 charts a future where health optimization, biomedical breakthroughs, and advanced technologies not only extend human life but enhance its quality and resilience on a global scale. It explores how longevity innovation—rooted in cutting-edge fields like regenerative medicine, artificial intelligence, and genomics—can be harmonized to address the collective survival and thriving of humanity, not just as individuals but as a global species.
As we move towards the year 2027, Longevity Industry 3.0 outlines how to accelerate the Longevity Industrialization process, from technological advancements to global policy frameworks that prioritize intergenerational equity, global health systems, and financial systems supporting longevity. The book is a call to action for governments, corporations, and citizens to rethink our approach to aging, health, and human potential—and to set the stage for a future where healthy longevity is not an ideal, but a global reality.
Book Description
In Longevity Industry 3.0, the authors take the pioneering concepts established in Longevity Industry 1.0 and Longevity Industry 2.0 to their logical and urgent next step: the practical, species-wide impact of the longevity revolution. Longevity Industry 1.0 introduced the foundational Longevity Industry framework, detailing the vast and complex ecosystem of health, science, and finance that governs our understanding of aging and healthspan. Longevity Industry 2.0 expanded upon this framework, integrating DeepTech, AI, and biotechnology to create stable systems for the accelerated development of longevity-focused innovations. Now, in Longevity Industry 3.0, the focus shifts to the long-term survival of humanity, leveraging technologies not only for individual health optimization but for global societal transformation.
Longevity Industry 3.0 envisions a future where longevity is central to global economic development, public health, and societal structure. It acknowledges the need for a proactive approach to aging, focusing on preventive health, regenerative medicine, and the seamless integration of AI and big data to create systems that enhance the healthspan of every individual, while simultaneously addressing the existential risks posed by challenges like climate change, pandemics, and technological risks.
From health-adjusted life expectancy (HALE) economies to intergenerational longevity governance, this book offers strategies, frameworks, and case studies that demonstrate how the Longevity Industry will drive the 5th Industrial Revolution (5IR). By integrating the lessons learned from space medicine, biotechnologies, and AI, Longevity Industry 3.0 calls for a holistic approach that unites science, policy, and finance to secure the longevity of humanity in the face of complex challenges.
Core Concepts
1. From Individual Longevity to Species-Wide Strategies: Transitioning from focusing solely on individual health to developing global frameworks for health optimization and species-wide longevity.
2. Technological Integration: Leveraging DeepTech, AI, big data, biotechnology, and regenerative medicine to optimize health and manage the aging process on a global scale, addressing pandemics, environmental challenges, and biotechnological risks.
3. Health-Based Economies: Shifting from capital-based to health-based economies, with Health-Adjusted Life Expectancy (HALE) and Quality-Adjusted Life Years (QALY) becoming the foundation for global prosperity.
4. Longevity Governance and Policy: The need for global policy frameworks and the creation of Longevity Councils to manage the integration of longevity technologies into public health systems, ensuring intergenerational equity and sustainable health systems.
5. Financial Models for Longevity: The rise of Longevity-focused financial products, such as Longevity Futures, insurance models, and investment funds, to support longevity innovations and ensure the equitable distribution of longevity technologies.
6. Global Longevity Strategy: A species-wide strategy for enhancing longevity, incorporating lessons from space medicine and regenerative medicine to address existential risks and ensure humanity's long-term survival both on Earth and in potential space habitats.
How This Book Follows on from LI1.0 and LI2.0
Longevity Industry 1.0 laid the foundation for understanding the Longevity sector by providing a framework that defined and mapped the ecosystem of technologies, industries, and markets that intersect with aging and longevity. It recognized the growing importance of longevity as a key driver for global economic change and social evolution.
Longevity Industry 2.0 expanded upon this initial framework by focusing on the maturation of the Longevity sector, introducing DeepTech solutions, AI, and biotechnology as key tools in the acceleration of the Longevity revolution. It explored the stabilization of the Longevity Industry, identifying the technologies and innovations that were ready to drive the next wave of industrialization.
Building on both of these foundational works, Longevity Industry 3.0 amplifies the impact of the previous phases, scaling the benefits of longevity from individual health and technological innovation to global survival. This volume moves beyond just the acceleration of innovation and focuses on the practical, humanitarian impact of longevity technologies on a global scale, addressing existential risks and building a sustainable future for humanity.
Where LI1.0 and LI2.0 were about defining and developing the industry, LI3.0 is about achieving its transformative humanitarian goals and integrating these advancements into a global framework that ensures the health and longevity of humanity well into the 21st century and beyond.
Technological Innovation: DeepTech, AI, regenerative medicine, and gene editing enable personalized health interventions, predictive diagnostics, and scalable longevity solutions.
Global Public Health: Longevity societies require preventive care, early disease detection, and equitable healthspan extension through biomarker-driven systems and global health policies.
Financial Systems & Longevity Economy: Longevity insurance, futures, and investment funds create stable growth ecosystems, addressing aging challenges and ensuring equitable access to technologies.
Intergenerational & Policy Adaptation: Longevity policies focus on balancing health, wealth, work, education, and retirement across generations, ensuring stability and equitable resource distribution.
Preface
-
Setting the Stage for Longevity Industry 3.0: A brief introduction to the evolution from Longevity Industry 1.0 and 2.0 into a new phase focused on global sustainability and species-wide longevity.
-
Humanity’s Long-Term Health: Expanding from individual health to collective strategies that address the future longevity of the entire human race, including adaptation to the challenges of aging, health disparities, and global threats.
.jpg)
Chapter 1: The Paradigm Shift — From Aging Societies
to Longevity Societies
-
Longevity Societies vs. Aging Societies: Exploring the transition from focusing solely on aging to a comprehensive Longevity society that aims for healthier and longer lives for all.
-
The Social and Structural Implications: Changes in education, employment, intergenerational relationships, and community engagement to accommodate a world where longer, healthier lives are the norm.
-
The Demographic Transition: Understanding the implications of longer life expectancy and how it affects global health, wealth, and societal structures.
Chapter 2: Global Health Optimization—Beyond Individual Longevity
-
Universal Health and Longevity Strategies: Building a species-wide health framework that integrates advanced biomedicine, AI, and regenerative technologies to optimize human longevity across different populations.
-
Preventive Health and Lifelong Healthspan: Shifting from disease treatment to health optimization throughout life, with a focus on preventive medicine, personalized health, and biomarker-driven health strategies.
-
Longevity Councils and Global Policy: The role of Longevity councils and coordinated international policy to manage and support global longevity initiatives.
Chapter 3: Technological Integration for Human Longevity
-
AI, Big Data, and Personalized Medicine: How AI and big data can create personalized health solutions, making predictive diagnostics and longevity-focused therapies a reality for global populations.
-
Regenerative Medicine and Gene Therapy: Harnessing the potential of stem cells, tissue regeneration, and gene therapies to address aging at the cellular level.
-
Longevity Tech for All: How biotechnologies and nanomedicine can be scaled to benefit not just individual health, but the broader global population, supporting longer, healthier lives.
Chapter 4: Global Health Frameworks—Managing Humanity’s Long-Term Survival
-
Existential Risk Management: Managing not just aging but global threats such as climate change, pandemics, and other existential risks through integrated biotechnologies and public health strategies.
-
Resilience Building for Humanity: Leveraging technological advancements to create systems that support human survival on Earth and prepare for long-term sustainability in a rapidly changing world.
Chapter 5: From Health-Based Economies to
Longevity-Driven Economies
-
Health-Adjusted Life Expectancy (HALE) and QALY Economies: Transitioning from traditional capital-based economies to health-based economies, focusing on the value of health and longevity as key economic assets.
-
Longevity as a Driver of Economic Growth: Understanding how longer, healthier lives contribute to increased human capital, productivity, and global prosperity, reshaping economic systems.
-
Redefining Retirement and Wealth Management: How financial systems must adapt to multi-stage lives, with new financial products and models for saving, investing, and wealth preservation across longer life spans.
Chapter 6: Policy, Governance, and Ethics in
Longevity Industry 3.0
-
Global Governance for Longevity: The need for international treaties and policies that manage the integration of longevity technologies and healthcare systems at a global scale.
-
Ethical Frameworks for Longevity: Addressing the ethical implications of longevity technologies, such as equitable access, intergenerational fairness, and the responsibilities of governments and corporations.
-
Creating Longevity States: How countries can become Longevity hubs, fostering Longevity-centered policies, healthcare infrastructure, and economic models.
.jpg)
Chapter 7: Financial Systems for the Longevity Economy
-
Funding the Longevity Revolution: How the financial sector is adapting to support the Longevity Industry through investments, longevity insurance, and new financial instruments.
-
Longevity-Focused Financial Products: The rise of Longevity Futures, exchange-traded products, and specialized investment funds to support longevity innovations and scale their application globally.
-
Sustainable Financial Infrastructure: Building a financial ecosystem capable of supporting the multi-trillion-dollar longevity sector while ensuring equitable access and sustainable growth.
.jpg)
Chapter 8: Synergizing Technologies—From Health Optimization to Global Longevity
-
The Cross-Sector Synergy: How AI, regenerative medicine, and biotechnologies are not just advancing individual health but also creating systems that optimize global longevity.
-
Technological Convergence: How the integration of health tech, fintech, and socio-tech is creating new models for governance, healthcare, and personal longevity management at the species level.
Chapter 9: Public Engagement and Building Global Consensus
-
Engaging the Public in Longevity: Strategies for global education and public awareness to build support for longevity-focused policies and technologies.
-
Inclusive Dialogue and Collaboration: The importance of collaborative international efforts and community-driven initiatives to ensure longevity benefits are universally accessible.
Chapter 10: Towards 2027 — Accelerating Longevity Industrialization
-
Expediting the Path to Practical Impact: How we can accelerate the Longevity Industrialization process ahead of traditional timelines to achieve global health benefits and a sustainable future by 2027.
-
Key Milestones and Roadmaps: Setting clear, actionable goals for governments, organizations, and individuals to drive Longevity Industry 3.0 forward in the next 5 years.
Conclusion: The Future of Humanity—Longevity for All
-
Beyond Survival to Thriving: The ultimate goal of Longevity Industry 3.0 is not just to extend life but to ensure human flourishing and sustainability for the entire global population.
-
Building a Legacy for Future Generations: Creating a world where longevity is a fundamental human right and a cornerstone of global prosperity, health, and social harmony.
About the Author
Dmitry Kaminskiy is an innovative entrepreneur, investor, author and philanthropist dedicated to impact investment and ethical business, with a focus on engineering the accelerated trajectory of progressive technological development for the benefit of humanity.
Mr. Kaminskiy is a co-founder and managing partner of Deep Knowledge Group - a consortium of commercial and non-profit organizations active on many fronts in the realm of DeepTech and Frontier Technologies (AI, Longevity, Precision Medicine, FinTech, GovTech, InvestTech), ranging from scientific research to investment, entrepreneurship, analytics, policy and philanthropy.
-
He leads the activities of the consortium’s venture arms - Deep Knowledge Ventures, an investment fund focused on DeepTech and advanced science projects, and Longevity.Capital, which prioritizes the convergence of Longevity and Artificial Intelligence, areas in which it has unparalleled investment and exit strategies.
-
He is a frequent speaker on the topics of AI and Longevity, including conferences organized in London by The Economist “Aging Societies and The Business of Longevity”, Financial Times “Smart Machines vs Smart People”, at the Future Finance Forum in Seoul “AI in Finance”, “Precision Medicine World Conference" in Silicon Valley, as well as several others at Oxford and Cambridge Universities.
Mr. Kaminskiy serves as managing trustee of Biogerontology Research Foundation, the UK’s oldest Longevity focused charity.